The Blokes testosterone offer includes a monthly-looking headline and a much more specific payment schedule further down the page. Read them together. The lowest advertised rate comes with a year paid upfront, and the other listed options also require a multi-month commitment.

We reviewed the official Joi + Blokes TRT page and supporting primary material on September 26, 2026. This article describes the published offer and its unresolved questions. It does not report personal treatment, a pharmacy inspection, or independently measured clinical results.

KEEP IN MIND

A few things to remember.

  • The $99 monthly equivalent requires a $1,188 annual prepayment.
  • Confirm location access and the precise medication and pharmacy.
  • Read the GLP-1 warning letter in its own scope; its later resolution is unverified.

Know the commitment before selecting a plan

The three published choices require $447 for three months, $774 for six months, or $1,188 for 12 months. Their displayed monthly equivalents are $149, $129, and $99 respectively. The annual figure is therefore not an offer to try a single month for $99.

Ask when the next renewal occurs and what happens if you need to stop earlier for medical or personal reasons. A cancellation process may prevent another renewal without necessarily refunding the unused portion of a current term. Obtain the terms for your actual plan before payment. Our cost planner can organize confirmed charges, but cannot decide what an ambiguous refund clause promises.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions

Check location and assessment requirements first

The provider lists states where it says TRT cannot be prescribed or shipped. Confirm current access for your home address before paying for an assessment. A laboratory or consultation offering should not be assumed to guarantee access to every medicine in the company’s catalog.

The clinical discussion needs to establish whether testosterone treatment is indicated. Bring symptoms, previous results, medication details, and fertility goals. Ask how a low result is confirmed and what happens if another explanation is more likely. A symptom checklist or a desire for better energy does not replace the evaluation described in professional guidance.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · Endocrine Society: testosterone therapy clinical guidance

Ask for the prescription that would be dispensed

Blokes names testosterone cypionate in its program and notes that some medicines may be compounded. Request the specific preparation and pharmacy rather than assuming that every patient receives the same manufactured or compounded product. FDA approval belongs to a product, not to the overall appearance of a provider’s website.

Compounded preparations are not FDA approved. Ask the clinician why the proposed option is appropriate and request practical instructions from the pharmacy. Our medication questions can help you record the answers. This review does not supply a concentration, injection schedule, or patient-specific pharmacy that the public offer has not established.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · FDA: understanding the risks of compounded drugs

A quarterly panel should have a named reviewer

The package advertises quarterly hormone labs alongside clinician care and messaging. Ask what is in the panel, whether initial testing is included, and how additional or earlier testing is handled. Also establish who will explain the results and how you can request a discussion if something changes between scheduled checks.

The hematocrit article explains why a blood-count result is different from a testosterone level. No single panel can substitute for the history and clinical judgment needed to interpret it. We have not evaluated Blokes’ response times or how its clinical team handles an abnormal result in practice; the advertised features remain provider descriptions.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · Pfizer: Depo-Testosterone prescribing information

Consider the FDA letter without changing its meaning

A June 8, 2026 FDA warning letter to Joi and Blokes addresses promotion of compounded semaglutide and tirzepatide, including statements and labeling that represented the compounder. The subject is those GLP-1-related products and their promotion. It is not a finding about the quality or outcome of a particular testosterone prescription.

We did not establish the letter’s later resolution or current enforcement status. The primary record is linked so readers can assess its actual scope. If it matters to your choice, ask the company what actions followed. Neither ignoring the record nor treating it as proof of an unrelated TRT problem would make the review more accurate.

Sources: FDA: June 8, 2026 warning letter concerning Joi + Blokes compounded GLP-1 promotion

Compare the plan with your need for flexibility

A longer prepaid period can lower a monthly equivalent while committing more money before the next medical reassessment. Ask what happens if the dose, medicine, or route changes and whether the unused portion of the original supply has any financial effect. The care team should explain the clinical transition separately from the billing adjustment.

Our Blokes versus Hone comparison contrasts the offer with membership-plus-medication pricing. The prescription-change shortlist gives more questions to ask before enrollment. A sensible decision accounts for state access, a clearly identified prescription, an understandable follow-up relationship, and obligations you can accept even if the first treatment plan needs revision.

Sources: Joi + Blokes: TRT plan commitments, products, labs, and state restrictions · Hone Health: Basic and Premium memberships and starting assessment

Sources you can check

Provider pages describe commercial offers. Medical references provide context. Checked September 26, 2026; prices and availability can change.

  1. Joi + Blokes: TRT plan commitments, products, labs, and state restrictions
  2. Endocrine Society: testosterone therapy clinical guidance
  3. FDA: understanding the risks of compounded drugs
  4. Pfizer: Depo-Testosterone prescribing information
  5. FDA: June 8, 2026 warning letter concerning Joi + Blokes compounded GLP-1 promotion
  6. Hone Health: Basic and Premium memberships and starting assessment

Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.